BioLife Solutions Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $13.46
- Today's High:
- $14.03
- Open Price:
- $13.58
- 52W Low:
- $12.6
- 52W High:
- $26.96
- Prev. Close:
- $13.76
- Volume:
- 285470
Company Statistics
- Market Cap.:
- $1.06 billion
- Book Value:
- 8.272
- Revenue TTM:
- $163.24 million
- Operating Margin TTM:
- -25.27%
- Gross Profit TTM:
- $54.07 million
- Profit Margin:
- -89.5%
- Return on Assets TTM:
- -5.21%
- Return on Equity TTM:
- -34.93%
Company Profile
BioLife Solutions Inc had its IPO on 1989-11-22 under the ticker symbol BLFS.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. BioLife Solutions Inc has a staff strength of 466 employees.
Stock update
Shares of BioLife Solutions Inc opened at $13.58 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $13.46 - $14.03, and closed at $14.
This is a +1.74% increase from the previous day's closing price.
A total volume of 285,470 shares were traded at the close of the day’s session.
In the last one week, shares of BioLife Solutions Inc have increased by +4.48%.
BioLife Solutions Inc's Key Ratios
BioLife Solutions Inc has a market cap of $1.06 billion, indicating a price to book ratio of 2.0333 and a price to sales ratio of 4.9132.
In the last 12-months BioLife Solutions Inc’s revenue was $163.24 million with a gross profit of $54.07 million and an EBITDA of $-26120000. The EBITDA ratio measures BioLife Solutions Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, BioLife Solutions Inc’s operating margin was -25.27% while its return on assets stood at -5.21% with a return of equity of -34.93%.
In Q1, BioLife Solutions Inc’s quarterly earnings growth was a positive 640% while revenue growth was a positive 4.1%.
BioLife Solutions Inc’s PE and PEG Ratio
- Forward PE
- 625
- Trailing PE
- 0
- PEG
- 63.2
Its diluted EPS in the last 12-months stands at $-3.41 per share while it has a forward price to earnings multiple of 625 and a PEG multiple of 63.2. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BioLife Solutions Inc’s profitability.
BioLife Solutions Inc stock is trading at a EV to sales ratio of 5.2445 and a EV to EBITDA ratio of -30.7717. Its price to sales ratio in the trailing 12-months stood at 4.9132.
BioLife Solutions Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $446.47 million
- Total Liabilities
- $47.32 million
- Operating Cash Flow
- $2.93 million
- Capital Expenditure
- $3.30 million
- Dividend Payout Ratio
- 0%
BioLife Solutions Inc ended 2024 with $446.47 million in total assets and $0 in total liabilities. Its intangible assets were valued at $446.47 million while shareholder equity stood at $-260629000.00.
BioLife Solutions Inc ended 2024 with $0 in deferred long-term liabilities, $47.32 million in other current liabilities, 43000.00 in common stock, $-260629000.00 in retained earnings and $224.74 million in goodwill. Its cash balance stood at $19.11 million and cash and short-term investments were $56.94 million. The company’s total short-term debt was $4,317,000 while long-term debt stood at $23.69 million.
BioLife Solutions Inc’s total current assets stands at $132.79 million while long-term investments were $7.09 million and short-term investments were $35.78 million. Its net receivables were $30.34 million compared to accounts payable of $15.53 million and inventory worth $41.33 million.
In 2024, BioLife Solutions Inc's operating cash flow was $2.93 million while its capital expenditure stood at $3.30 million.
Comparatively, BioLife Solutions Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $14
- 52-Week High
- $26.96
- 52-Week Low
- $12.6
- Analyst Target Price
- $30.71
BioLife Solutions Inc stock is currently trading at $14 per share. It touched a 52-week high of $26.96 and a 52-week low of $26.96. Analysts tracking the stock have a 12-month average target price of $30.71.
Its 50-day moving average was $16.38 and 200-day moving average was $20.1 The short ratio stood at 10.35 indicating a short percent outstanding of 0%.
Around 671.7% of the company’s stock are held by insiders while 9161.6% are held by institutions.
Frequently Asked Questions About BioLife Solutions Inc
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; ultra-low temperature mechanical freezers; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.